List of Overseas IVF Countries and Hospitals: Global Assisted Reproduction Center Distribution Characteristics and Selection Reference

Opening: Direct Answer

The choice of overseas IVF countries and hospitals is the first step in treatment decision-making, directly impacting legal compliance, medical technology pathways, cost budgets, and overall cycle scheduling. The following content is compiled based on public medical information and industry consensus from major global assisted reproduction countries for reference.

I. Differences in Legal Environments for Assisted Reproduction Across Countries

The degree of legal regulation of assisted reproductive technology varies by country, directly affecting the medical procedures that can be performed, the applicable population, and embryo handling methods. The table below summarizes the differences in legal environments across major countries:

II. Distribution and Characteristics of Hospitals in Major Countries

The following lists some representative reproductive centers by country, focusing on their medical characteristics and technical directions. This does not constitute a ranking or recommendation. Choices should be made based on individual medical needs, language communication, and logistical support.

Thailand

• Jetanin Institute: A long-established reproductive center in Bangkok, known for its PGT technology and stable embryo laboratory, with high cycle volume and mature standardized processes.
• BNH Hospital: Offers full-cycle assisted reproduction services, including egg donation, sperm donation, and embryo freezing; extensive experience in coordinating international patients.
• First Fertility: Positioned in the mid-to-high-end market, focusing on personalized ovulation induction protocols, with a relatively comprehensive laboratory quality control system.
• Rama 9 Hospital: A reproductive center within a general hospital, offering multidisciplinary support, suitable for patients with other gynecological or endocrine issues.
• Phyathai Hospital: Has several branches; its reproductive center is noted for high cost-effectiveness and relatively short cycle waiting times.

Thailand's overall advantages include: a relatively mature assisted reproduction industry chain, extensive experience serving international patients, high prevalence of PGT technology, and costs at the median level in Asia. Note that some hospitals have internal indication restrictions on embryo genetic testing.

United States

• HRC Fertility: Has branches in California, Nevada, etc., known for high pregnancy rates and advanced embryo culture environments, with extensive experience in PGT-A and PGT-M.
• CCRM (Colorado Center for Reproductive Medicine): Multiple branches across the US, renowned for laboratory research capabilities and individualized stimulation protocols, suitable for complex cases.
• RMA (Reproductive Medicine Associates): Covers New Jersey, New York, California, etc., emphasizes data-driven treatment protocols, with high cycle volume.
• Shady Grove Fertility: A large reproductive center on the East Coast, known for standardized processes and Shared Risk programs, suitable for patients with limited budgets.
• Boston IVF: Collaborates with Harvard Medical School affiliated teaching hospitals, strong research capabilities, with deep expertise in egg freezing and embryo cryopreservation.

US advantages include: high legal tolerance, cutting-edge technology (especially genetic testing and embryo culture), uniform laboratory standards; main challenges are high cost (approximately $25,000-$40,000 per cycle) and the need for longer visa and travel planning.

Malaysia

• Alpha Hospital: Located in Kuala Lumpur, one of the earlier private hospitals in Malaysia to offer assisted reproduction, with relatively new laboratory equipment and a high proportion of international patients.
• Tropicana Medical Centre: A comprehensive private hospital; its reproductive center offers one-stop services, including fertility preservation and embryo genetic testing.
• Tung Shin Hospital: A charitable hospital with a long history; its reproductive center charges relatively affordable fees, suitable for budget-sensitive patients.

Malaysia's characteristics: costs are relatively low in Asia (approximately RMB 40,000-70,000 per cycle), high English proficiency, medical system influenced by the UK; but legal restrictions are significant, making it unsuitable for those needing surrogacy or egg donation.

Japan

• Kato Ladies Clinic: A globally renowned mild stimulation IVF center, known for low-dose stimulation and high egg utilization rates, suitable for those with diminished ovarian reserve or sensitivity to hormones.
• Hanabusa Women's Clinic: Located in Kobe, specializes in natural cycle and mild stimulation protocols, focusing on embryo culture details.
• Sugiyama Clinic: Has branches in Tokyo, Nagoya, etc., offers conventional IVF and PGT services, with highly refined cycle management.

Japan's advantages in assisted reproduction include: mature mild stimulation technology, standardized medication safety, strict quality control of culture dishes and media; however, laws strictly restrict egg donation and surrogacy, and the scope of PGT indications is narrow.

Georgia

• New Life Georgia: A well-known reproductive center in Tbilisi, offering full-cycle services including IVF, egg donation, and surrogacy, with extensive experience in coordinating international patients.
• Chachava Clinic: Specializes in surrogacy services, with mature integration of legal team and medical procedures, suitable for those with clear surrogacy needs.

Georgia's legal environment is relatively friendly towards surrogacy and egg donation, with costs low within Europe (approximately €15,000-€25,000 per cycle); however, attention must be paid to verifying medical institution qualifications and the completeness of subsequent legal documents.

Russia

• Art-IVF: A large reproductive center in Moscow, offering a full spectrum of services including PGT, egg donation, and surrogacy, with laboratory equipment meeting international standards.
• Avicenna Clinic: Noted for personalized diagnosis and treatment and relatively high pregnancy rates, with a well-established international patient service process.
• Sparta Clinic: Has a branch in St. Petersburg, focuses on the stability of the embryo culture environment, with standardized cycle management.

Russia's advantages include high legal tolerance for assisted reproduction (allowing surrogacy and egg donation) and lower costs compared to Western Europe; however, recent geopolitical factors may affect medical travel convenience, requiring advance assessment of visa and transportation arrangements.

Spain

• IVI (Instituto Valenciano de Infertilidad): One of the largest assisted reproduction groups in Europe, with branches in Valencia, Madrid, Barcelona, etc., with extensive experience in egg donation programs.
• Madrid Fertility Centre: Focuses on individualized diagnosis and treatment, with specialized protocols for embryo genetic testing and management of recurrent implantation failure.

Spain is a popular destination for egg donation in Europe, with a mature anonymous donation system and relatively short waiting times for egg donation; surrogacy is legally prohibited, so those needing surrogacy must look to other countries.

III. Core Reference Indicators for Choosing a Hospital

When choosing an overseas IVF hospital, the following indicators offer more practical reference value than the "success rate" number:

• Embryology Laboratory Grade: Whether it has stable incubators, real-time monitoring systems (e.g., EmbryoScope), and standardized quality control procedures. The laboratory environment directly affects embryo developmental potential.
• Embryologist Experience: The proficiency of senior embryologists in egg activation, ICSI (Intracytoplasmic Sperm Injection) procedures, and embryo freezing/thawing is a hidden but crucial factor.
• Cycle Volume and Scale: Hospitals with high annual cycle volumes generally have more experience in process standardization and handling unexpected situations.
• PGT Technology and Genetic Counseling: If genetic testing is involved, confirm whether the hospital has PGT-A/PGT-M qualifications and an independent genetic counseling team.
• International Patient Support Services: Including translation support, medical coordination, visa assistance, accommodation arrangements, etc. Lack of support services significantly increases time and communication costs.

IV. Actual Overseas IVF Process and Timeline

From the initial consultation to embryo transfer, the following stages are typically involved, spanning approximately 3-6 months depending on the speed of completing tests, the ovulation induction protocol, and whether PGT is needed:

V. Most Easily Overlooked Details

• Passport Validity & Visa Type: Most countries require passport validity exceeding 6 months; medical visas (e.g., Thailand's "Medical Visa") differ from tourist visas in permitted stay duration, so confirm in advance.
• Validity of Test Reports: Some infectious disease screenings (e.g., HIV, syphilis) are typically valid for 3-6 months, while chromosome tests are valid for life. Check the validity of each report with the hospital before departure.
• Embryo Freezing & Shipping Terms: If planning to transport embryos back to your home country, confirm whether the hospital offers embryo freezing and shipping services, and whether the destination country allows embryo import.
• Medical Accuracy of Translation: Medical translation requires not only language skills but also familiarity with assisted reproduction terminology. It is recommended to use the hospital's official translation services or translators with a medical background.
• Insurance Coverage: Check with your insurance company whether complications from overseas IVF (e.g., OHSS, post-retrieval bleeding) are covered.

VI. Frequently Asked Questions

Q1: Can I still do overseas IVF with low AMH? Which countries are more suitable?

Low AMH indicates diminished ovarian reserve but is not a contraindication for IVF. Some hospitals in Japan and Thailand have extensive experience with mild stimulation and natural cycles, suitable for poor ovarian responders. Centers like CCRM in the US also offer individualized protocols for DOR (Diminished Ovarian Reserve). The key is to choose a hospital with specific protocols for low AMH, rather than blindly pursuing high-dose stimulation.

Q2: Does the male partner need to accompany the entire overseas IVF process?

At minimum, the male partner needs to participate twice: once for pre-cycle semen analysis (some hospitals accept pre-frozen sperm), and once for sperm collection on the day of egg retrieval. If the partner cannot be present, confirm in advance whether the hospital allows the use of frozen sperm or third-party sperm sample transport.

Q3: Is PGT testing mandatory? When is it recommended?

PGT-A (aneuploidy screening) is recommended for: female age ≥38, recurrent implantation failure, recurrent miscarriage, or history of chromosomal abnormality in a previous pregnancy. PGT-M (monogenic disease testing) is suitable for couples known to carry pathogenic genes. PGT is not necessary for everyone; decisions should be made based on genetic counseling and doctor's advice.

Q4: What is the total cost range for overseas IVF?

Costs vary significantly by country and hospital: Thailand approx. RMB 80,000-150,000 per cycle; USA approx. $25,000-$40,000; Malaysia approx. RMB 40,000-70,000; Japan approx. RMB 80,000-120,000; Georgia approx. €15,000-€25,000. These figures exclude transportation, accommodation, and additional medication costs. PGT testing adds approximately RMB 10,000-30,000.

VII. Practitioner Observations

In overseas assisted reproduction coordination work, the following points are worth noting:

• "Success rate" numbers need to be broken down. Different hospitals use different statistical methods – some report "pregnancy rate per single transfer," others report "cumulative pregnancy rate" (including multiple transfers), and still others report "live birth rate." It is advisable to ask hospitals directly for age-stratified live birth rate data.
• Laboratory stability is more important than reputation. We have encountered cases where "well-known" hospitals experienced cycle performance fluctuations due to laboratory relocation or key personnel changes during specific periods. On-site visits or independent third-party evaluations of the laboratory's recent six-month performance are worthwhile.
• Legal risks are often underestimated. Especially when involving surrogacy, egg donation, or cross-border embryo transport, besides the laws of the destination country, it is necessary to understand the recognition of such actions by your home country's laws. Some countries have seemingly lenient laws, but practical operations may face uncertainties in document notarization and parentage determination.
• Decision paths should be short, not long. We have encountered many cases where individuals compared multiple countries and hospitals for over a year, ultimately missing the optimal window due to increasing age and declining ovarian function. After initial screening, setting a decision deadline (e.g., within 3 months) is helpful.

VIII. Risk Reminders

Overseas IVF involves multiple medical, legal, financial, and logistical factors. The following risks should be considered:

• Medical Risks: Ovarian Hyperstimulation Syndrome (OHSS) may occur during ovulation induction; egg retrieval surgery carries risks of bleeding, infection, and other complications. Choosing a hospital with comprehensive emergency care capabilities can reduce risks.
• Legal Risks: The legal validity of surrogacy, egg donation, and cross-border embryo transport varies by country. It is recommended to obtain independent legal advice before starting treatment.
• Financial Risks: Some hospitals require full payment for the cycle before treatment. Refund policies vary significantly if the cycle is cancelled or interrupted. Read contract terms carefully before payment.
• Information Asymmetry Risk: Online hospital reviews and "success rate" claims may involve information filtering. It is advisable to cross-verify using third-party medical databases (e.g., CDC, ESHRE public reports) or independent medical consultants.

IX. Reminders for Special Populations

Advanced Age (≥40 years): Prioritize hospitals with mature PGT technology and specific protocols for poor ovarian response (e.g., CCRM in the US, Jetanin in Thailand, Kato Ladies Clinic in Japan). Avoid delays in timeline planning; enter the cycle as soon as basic tests are completed.

Those Needing Surrogacy: Focus on the legal stability of the destination country, the legal enforceability of surrogacy contracts, and the integration process between the medical institution and the surrogacy agency. Georgia and some US states (e.g., California) are currently popular directions for consultation.

Those with Recurrent Implantation Failure: Choose a comprehensive reproductive center capable of performing Endometrial Receptivity Analysis (ERA), hysteroscopy, and immunological evaluation, rather than just focusing on "high success rate" hospitals.

X. Suggestions for Next Steps

After gaining a preliminary understanding of overseas IVF countries and hospital lists, it is recommended to proceed with the following steps:

1. Complete your own medical evaluation: Including basic tests like AMH, FSH, antral follicle count, semen analysis, chromosome karyotype, to clarify your medical needs and boundaries.
2. Identify 2-3 target countries: Based on legal environment, medical characteristics, cost budget, and travel convenience, narrow down the candidate countries.
3. Screen matching hospitals: For each candidate country, screen 2-3 hospitals, focusing on laboratory grade, PGT capabilities, and international patient support services.
4. Remote consultation and plan confirmation: Conduct remote video consultations with hospitals to confirm the initial plan, cost breakdown, and cycle timeline.
5. Arrange documents and travel: Apply for passport/visa, book flights and accommodation, arrange translation and local support.

The entire decision-making process is recommended to be completed within 2-3 months to avoid delaying treatment due to excessive comparison.

End: Process Reminder